In vitro Combined Inhibitory Activities of β-Lactam Antibiotics and Clavulanic Acid Against bla_KPC-2-Positive Klebsiella pneumoniae

References

• Bennett JW, Herrera ML, Lewis JS 2nd, Wickes BW, Jorgensen JH. KPC-2-producing Enterobacter cloacae and pseudomonas putida coinfection in a liver transplant recipient. Antimicrob Agents Chemother. 2009;53(1):292–294. doi:10.1128/AAC.00931-0818852270
   PubMed Web of Science ®Google Scholar
• Cai JC, Zhou HW, Zhang R, Chen GX. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother. 2008;52(6):2014–2018. doi:10.1128/AAC.01539-0718332176
   PubMed Web of Science ®Google Scholar
• Zhang X, Lü X, Zong Z. Enterobacteriaceae producing the KPC-2 carbapenemase from hospital sewage. Diagn Microbiol Infect Dis. 2012;73(2):204–206. doi:10.1016/j.diagmicrobio.2012.02.00722463869
   PubMed Web of Science ®Google Scholar
• Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae [published correction appears in Antimicrob Agents Chemother. 2008 Feb;52(2):809]. Antimicrob Agents Chemother. 2001;45(4):1151–1161. doi:10.1128/AAC.45.4.1151-1161.200111257029
   PubMed Web of Science ®Google Scholar
• Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785–796. doi:10.1016/S1473-3099(13)70190-723969216
   PubMed Web of Science ®Google Scholar
• Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother. 2007;51(2):763–765. doi:10.1128/AAC.01053-0617145797
   PubMed Web of Science ®Google Scholar
• Liang Y, Yin X, Zeng L, Chen S. Clonal replacement of epidemic KPC-producing Klebsiella pneumoniae in a hospital in China. BMC Infect Dis. 2017;17(1):363. doi:10.1186/s12879-017-2467-928535790
   PubMed Web of Science ®Google Scholar
• Liu J, Yu J, Chen F, et al. Emergence and establishment of KPC-2-producing ST11 Klebsiella pneumoniae in a general hospital in Shanghai, China. Eur J Clin Microbiol Infect Dis. 2018;37(2):293–299. doi:10.1007/s10096-017-3131-429282569
   PubMed Web of Science ®Google Scholar
• Chen C, Zhang Y, Yu SL, et al. Tracking Carbapenem-Producing Klebsiella pneumoniae outbreak in an intensive care unit by whole genome sequencing. Front Cell Infect Microbiol. 2019;9:281. doi:10.3389/fcimb.2019.0028131440476
   PubMed Web of Science ®Google Scholar
• Cheng L, Cao XL, Zhang ZF, et al. Clonal dissemination of KPC-2 producing Klebsiella pneumoniae ST11 clone with high prevalence of oqxAB and rmtB in a tertiary hospital in China: results from a 3-year period. Ann Clin Microbiol Antimicrob. 2016;15:1. doi:10.1186/s12941-015-0109-x26786830
   PubMed Web of Science ®Google Scholar
• Chen L, Mathema B, Chavda KD, DeLeo FR, Bonomo RA, Kreiswirth BN. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol. 2014;22(12):686–696. doi:10.1016/j.tim.2014.09.00325304194
   PubMed Web of Science ®Google Scholar
• Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20(3):440–458. doi:10.1128/CMR.00001-0717630334
   PubMed Web of Science ®Google Scholar
• Walther-Rasmussen J, Høiby N. Class A carbapenemases. J Antimicrob Chemother. 2007;60(3):470–482. doi:10.1093/jac/dkm22617595289
   PubMed Web of Science ®Google Scholar
• Yu Y, Hu F, Zhu C, Chen E, Lu L, Gao Y. Use of next generation sequencing and synergy susceptibility testing in diagnosis and treatment of Carbapenem-Resistant Klebsiella pneumoniae blood stream infection. Case Rep Infect Dis. 2018;2018:3295605. doi:10.1155/2018/329560529607230
   PubMed Web of Science ®Google Scholar
• Poirel L, Kieffer N, Nordmann P. In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2016;71(1):156–161. doi:10.1093/jac/dkv29426416781
   PubMed Web of Science ®Google Scholar
• Daikos GL, Markogiannakis A. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? Clin Microbiol Infect. 2011;17(8):1135–1141. doi:10.1111/j.1469-0691.2011.03553.x21635663
   PubMed Web of Science ®Google Scholar
• Papp-Wallace KM, Bethel CR, Distler AM, Kasuboski C, Taracila M, Bonomo RA. Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase. Antimicrob Agents Chemother. 2010;54(2):890–897. doi:10.1128/AAC.00693-0920008772
   PubMed Web of Science ®Google Scholar
• Oliva A, D’Abramo A, D’Agostino C, et al. Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections. J Antimicrob Chemother. 2014;69(6):1718–1720. doi:10.1093/jac/dku02724521856
   PubMed Web of Science ®Google Scholar
• Qureshi ZA, Paterson DL, Potoski BA, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56(4):2108–2113. doi:10.1128/AAC.06268-1122252816
   PubMed Web of Science ®Google Scholar
• Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother. 2014;58(4):2322–2328. doi:10.1128/AAC.02166-1324514083
   PubMed Web of Science ®Google Scholar
• Ji S, Lv F, Du X, et al. Cefepime combined with amoxicillin/clavulanic acid: a new choice for the KPC-producing K. pneumoniae infection. Int J Infect Dis. 2015;38:108–114. doi:10.1016/j.ijid.2015.07.02426255892
   PubMed Web of Science ®Google Scholar
• Sotto A, Foulongne V, Sirot D, Labia R, Jourdan J. Experimental application of the median-effect principle for in vitro quantification of the combined inhibitory activities of clavulanic acid and imipenem against IRT-4 beta-lactamase. Int J Antimicrob Agents. 2002;19(1):75–78. doi:10.1016/s0924-8579(01)00465-411814772
   PubMed Web of Science ®Google Scholar
• Muratani T, Yokota E, Nakane T, Inoue E, Mitsuhashi S. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam. J Antimicrob Chemother. 1993;32(3):421–429. doi:10.1093/jac/32.3.4218262864
   PubMed Web of Science ®Google Scholar
• Weterings V, Zhou K, Rossen JW, et al. An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread. Eur J Clin Microbiol Infect Dis. 2015;34(8):1647–1655. doi:10.1007/s10096-015-2401-226067658
   PubMed Web of Science ®Google Scholar
• Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature. Clin Infect Dis. 2009;49(2):271–274. doi:10.1086/60004219527172
   PubMed Web of Science ®Google Scholar
• Sonnevend Á, Ghazawi A, Hashmey R, et al. Multihospital occurrence of pan-resistant Klebsiella pneumoniae Sequence Type 147 with an ISEcp1-directed blaOXA-181 insertion in the mgrB gene in the United Arab Emirates. Antimicrob Agents Chemother. 2017;61(7):e00418–17. doi:10.1128/AAC.00418-1728438945
   PubMedGoogle Scholar
• Hampel B, Lode H, Bruckner G, Koeppe P. Comparative pharmacokinetics of sulbactam/ampicillin and clavulanic acid/amoxycillin in human volunteers. Drugs. 1988;35(Suppl 7):29–33. doi:10.2165/00003495-198800357-00007
   Web of Science ®Google Scholar
• Adam D, de Visser I, Koeppe P. Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination. Antimicrob Agents Chemother. 1982;22(3):353–357. doi:10.1128/aac.22.3.3537137979
   PubMed Web of Science ®Google Scholar
• Matho A, Mulqueen M, Tanino M, et al. High-dose versus standard-dose amoxicillin/clavulanate for clinically-diagnosed acute bacterial sinusitis: a randomized clinical trial. PLoS One. 2018;13(5):e0196734. doi:10.1371/journal.pone.019673429738561
   PubMed Web of Science ®Google Scholar
• deLemos AS, Ghabril M, Rockey DC, et al. Amoxicillin-clavulanate-induced liver injury. Dig Dis Sci. 2016;61(8):2406–2416. doi:10.1007/s10620-016-4121-627003146
   PubMed Web of Science ®Google Scholar
• Chams S, El Sayegh S, Hamdon M, Kumar S, Tegeltija V. Amoxicillin/clavulanic acid-induced pancreatitis: case report. BMC Gastroenterol. 2018;18(1):122. doi:10.1186/s12876-018-0851-630071846
   PubMed Web of Science ®Google Scholar
• Carlier M, Noë M, De Waele JJ, et al. Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients. J Antimicrob Chemother. 2013;68(11):2600–2608. doi:10.1093/jac/dkt24023800901
   PubMed Web of Science ®Google Scholar
• Fatima A, Shaikh M, Zahid H, Younus I, Khaliq SA, Khalid F. Clinical pharmacokinetics of clavulanic acid, a novel β-lactamase isolated from Streptomyces clavuligerus and its variability. Med Chem (Los Angeles). 2018. doi:10.5772/intechopen.79409
   Google Scholar
• Jones AE, Barnes ND, Tasker TC, Horton R. Pharmacokinetics of intravenous amoxycillin and potassium clavulanate in seriously ill children. J Antimicrob Chemother. 1990;25(2):269–274. doi:10.1093/jac/25.2.2692329104
   PubMed Web of Science ®Google Scholar
• Bassetti M, Peghin M, Pecori D. The management of multidrug-resistant Enterobacteriaceae. Curr Opin Infect Dis. 2016;29(6):583–594. doi:10.1097/QCO.000000000000031427584587
   PubMed Web of Science ®Google Scholar
• Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123. doi:10.1016/j.diagmicrobio.2010.12.00221398074
   PubMed Web of Science ®Google Scholar
• Le QP, Ueda S, Nguyen TN, et al. Characteristics of extended-spectrum β-Lactamase-producing Escherichia coli in retail meats and shrimp at a local market in Vietnam. Foodborne Pathog Dis. 2015;12(8):719–725. doi:10.1089/fpd.2015.195426110236
   PubMed Web of Science ®Google Scholar
• Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40(6):2153–2162. doi:10.1128/jcm.40.6.2153-2162.200212037080
   PubMed Web of Science ®Google Scholar